Search results
Ars Pharmaceuticals CEO sells over $900k in company stock By Investing.com
Investing.com· 8 hours agoARS Pharmaceuticals, Inc. (NASDAQ:SPRY) has reported a series ofstock transactions involving its...
Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Grows By 7.8%
ETF DAILY NEWS· 4 hours agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short...000 shares. Based ...
HC Wainwright Weighs in on EyePoint Pharmaceuticals, Inc.’s Q2 2024 Earnings (NASDAQ:EYPT)
ETF DAILY NEWS· 5 hours agoHC Wainwright analyst Y. Chen now expects that the company will earn ($0.48) per share for the quarter, down from their prior forecast of ($0.35). HC Wainwright currently ...
StockNews.com Initiates Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS)
ETF DAILY NEWS· 5 hours agoStockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on ...
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest
ETF DAILY NEWS· 4 hours agoAcurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) was the target of a significant increase in short interest in April. As of April 30th, there was short interest ...
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Insider Sells $42,352.72 in Stock
ETF DAILY NEWS· 5 days agoZentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) insider Diana Hausman sold 3,356 shares of the stock in a transaction that occurred on Thursday ...
Sarina Tanimoto Sells 100,000 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock
ETF DAILY NEWS· 5 days agoARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 100,000 shares of ARS Pharmaceuticals stock in ...
Research Analysts Issue Forecasts for X4 Pharmaceuticals, Inc.’s Q2 2024 Earnings (NASDAQ:XFOR)
ETF DAILY NEWS· 6 days agoX4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Stock analysts at Brookline Capital Management dropped their Q2 2024 earnings per share estimates ...
Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?
InvestorPlace· 2 days agoVirpax Pharmaceuticals (NASDAQ:VRPX) stock is down on Wednesday as the preclinical-stage ...
Kiniksa Pharmaceuticals Ltd (KNSA) may enjoy gains as insiders got busy in the recent days – Knox...
Knox Daily· 2 days agoIn the deal valued...Before that, Patel Sanj K sold 12,742 shares. Kiniksa Pharmaceuticals Ltd shares valued at $273,834 were divested by the CHAIRMAN & ...coverage, including ...